Blake Borgeson is the cofounder and CTO of Recursion Pharmaceuticals, where he is leading the computational development of a drug discovery platform combining high-throughput experiments and machine learning that is capable of finding potential treatments for hundreds of diseases rapidly and in parallel. Previously, he researched and built real-time navigation software for surgical procedures at the M.E. Müller Institute in Bern, Switzerland and cofounded BuildASign.com, an ecommerce company that currently employs over 350 in Austin, Texas. Blake holds a PhD in bioinformatics from UT Austin’s Marcotte Lab, where his research used machine learning to exploit new experimental techniques in rapidly mapping protein complexes, and a BS in electrical engineering from Rice University.
©2017, O'Reilly Media, Inc. • (800) 889-8969 or (707) 827-7019 • Monday-Friday 7:30am-5pm PT • All trademarks and registered trademarks appearing on oreilly.com are the property of their respective owners. • firstname.lastname@example.org